Retrospective testing for mpox virus in routine STI screens from men who have sex with men in England, August-October 2022.


Journal

Sexually transmitted infections
ISSN: 1472-3263
Titre abrégé: Sex Transm Infect
Pays: England
ID NLM: 9805554

Informations de publication

Date de publication:
Dec 2023
Historique:
received: 06 04 2023
accepted: 15 07 2023
medline: 27 11 2023
pubmed: 4 8 2023
entrez: 3 8 2023
Statut: ppublish

Résumé

A global outbreak of mpox (monkeypox) has been ongoing since 2022, with most cases in the UK detected in gay, bisexual and other men who have sex with men (GBMSM). Asymptomatic and pauci-symptomatic mpox infection has been reported outside of the UK. We aimed to investigate whether mpox could be detected in specimens from GBMSM in England who were attending sexual health services (SHSs) for asymptomatic sexually transmitted infection screening. Anonymised, residual clinical specimens from GBMSM undertaking routine asymptomatic screening for gonorrhoea ( During the collection period, 2927 clinical specimens (951 pharyngeal swabs, 1022 urine specimens and 954 rectal swabs) were obtained from 1159 GBMSM. Mpox virus was detected in four specimens from two participants who attended the same SHS at different times (the first during the week 8-12 of August, the second during the week 19-23 of September). One participant was positive in the urine specimen only, while the other tested positive at all three sites. A very low prevalence (2 of 1159, 0.17%) of mpox infection was detected in GBMSM attending SHS in England for asymptomatic NG/CT screening, suggesting that undetected infection in this population was unlikely to be a main driver of transmission. Confirmed mpox cases in the UK declined from over 1100 per month in June and July to 764 cumulatively during the collection period. These data give reassurance that the observed reduction in cases during the collection period was not due to undetected infection or changes in presentation among SHS attendees. Currently, there is insufficient evidence to support routine testing of asymptomatic GBMSM for mpox infection in England.

Identifiants

pubmed: 37536929
pii: sextrans-2023-055841
doi: 10.1136/sextrans-2023-055841
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

548-551

Informations de copyright

© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Rachel Pitt-Kendall (R)

UK Health Security Agency, London, UK Rachel.Pitt@ukhsa.gov.uk.

Clare Foster (C)

UK Health Security Agency, London, UK.

Michael Rayment (M)

Chelsea and Westminster Hospital NHS Foundation Trust, London, UK.

Beata Orzechowska (B)

UK Health Security Agency, London, UK.

Rufat Mammadov (R)

UK Health Security Agency, London, UK.

Suneeta Soni (S)

University Hospitals Sussex NHS Foundation Trust, Brighton, UK.

Simon Mortlock (S)

Preventx Limited, Sheffield, UK.

Jodie Owen (J)

UK Health Security Agency - Porton, Salisbury, UK.

Luke Uglow (L)

Preventx Limited, Sheffield, UK.

Michaela Joanne Day (MJ)

UK Health Security Agency, London, UK.

Rupa Rai Gurung (R)

UK Health Security Agency, London, UK.

Amber Savary-Trathen (A)

University Hospitals Sussex NHS Foundation Trust, Brighton, UK.

Rhian Jenkins (R)

University Hospitals Sussex NHS Foundation Trust, Brighton, UK.

Emma McGuire (E)

UK Health Security Agency, London, UK.

Natalie Gordon (N)

Preventx Limited, Sheffield, UK.

Sara Louise Day (SL)

Chelsea and Westminster Healthcare NHS Trust, London, UK.

Adrian M Kelly (AM)

Lead Commissioner Sexual Health e-Service, City of London Corporation, London, UK.

Charlotte Goward (C)

Preventx Limited, Sheffield, UK.

Kate Folkard (K)

UK Health Security Agency, London, UK.

Hannah Charles (H)

UK Health Security Agency, London, UK.

Hamish Mohammed (H)

UK Health Security Agency, London, UK.

Colin S Brown (CS)

UK Health Security Agency, London, UK.

Helen Fifer (H)

UK Health Security Agency, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH